FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377164009> ?p ?o ?g. }

• W4377164009 endingPage "1229" @default.
• W4377164009 startingPage "1217" @default.
• W4377164009 abstract "The efficacy of iGlarLixi, a fixed-ratio combination of basal insulin glargine 100 units/mL (iGlar) and the short-acting GLP-1 RA lixisenatide (Lixi), was established in people with type 2 diabetes (T2D) who were advancing therapy from oral antidiabetic drugs (OADs) and basal insulin (BI). This retrospective study aimed to evaluate the effectiveness and safety of iGlarLixi using real-world data from people with T2D in the Adriatic region countries. This was a non-interventional, retrospective, multicenter, cohort study with the collection of pre-existing data at iGlarLixi initiation and after 6 months of treatment in real-world clinical and ambulatory settings. The primary outcome was the change in glycated hemoglobin (HbA1c) at 6 months after iGlarLixi initiation. Key secondary outcomes included the proportion of people achieving HbA1c < 7.0%, the effect of iGlarLixi on fasting plasma glucose (FPG), body weight and body mass index (BMI). In this study, 262 participants (130 in Bosnia and Herzegovina, 72 in Croatia and 60 in Slovenia) initiated treatment with iGlarLixi. The participants had a mean ± SD age of 66.2 ± 7.9 years and the majority were women (58.0%). The mean baseline HbA1c was 8.9 ± 1.7% and the mean body weight was 94.3 ± 18.0 kg. After 6 months of treatment, the reduction in the mean HbA1c was statistically significant (1.11 ± 1.61%, 95% confidence internal [CI] 0.92, 1.31; p < 0.001), and the proportion of participants who achieved HbA1c < 7.0% had significantly increased from baseline (8.0–26.0%, p < 0.001). The change in mean FPG (mmol/L) levels was significant (2.7 ± 4.4 [95% CI 2.1, 3.2; p < 0.001]). The mean ± SD body weight and BMI were significantly reduced by 2.9 ± 4.3 kg (95% CI 2.3, 3.4; p < 0.001) and 1.3 ± 4.4 kg/m2 (95% CI 0.7, 1.8; p < 0.001), respectively. Two serious hypoglycemia episodes and one adverse gastrointestinal effect (nausea) were registered. This real-world study demonstrated the effectiveness of iGlarLixi for improving glycemic control and decreasing body weight in people with T2D who need to advance therapy from OADs or insulin." @default.
• W4377164009 created "2023-05-21" @default.
• W4377164009 creator A5002770606 @default.
• W4377164009 creator A5010003226 @default.
• W4377164009 creator A5032068938 @default.
• W4377164009 creator A5040004229 @default.
• W4377164009 creator A5081875581 @default.
• W4377164009 creator A5089705408 @default.
• W4377164009 creator A5091985933 @default.
• W4377164009 date "2023-05-21" @default.
• W4377164009 modified "2023-10-10" @default.
• W4377164009 title "Effectiveness and Safety of iGlarLixi in People with Type 2 Diabetes in Adriatic Region Countries: ENSURE-ADR, a Real-World Study" @default.
• W4377164009 cites W2067533175 @default.
• W4377164009 cites W2099468119 @default.
• W4377164009 cites W2126862523 @default.
• W4377164009 cites W2292172438 @default.
• W4377164009 cites W2376943461 @default.
• W4377164009 cites W2410056512 @default.
• W4377164009 cites W2487055106 @default.
• W4377164009 cites W2514766623 @default.
• W4377164009 cites W2516820342 @default.
• W4377164009 cites W2521422828 @default.
• W4377164009 cites W2559748650 @default.
• W4377164009 cites W2748858803 @default.
• W4377164009 cites W2791601373 @default.
• W4377164009 cites W2896796427 @default.
• W4377164009 cites W3090769556 @default.
• W4377164009 cites W3125743995 @default.
• W4377164009 cites W3133770873 @default.
• W4377164009 cites W3188644133 @default.
• W4377164009 cites W4282004624 @default.
• W4377164009 cites W4296802076 @default.
• W4377164009 doi "https://doi.org/10.1007/s13300-023-01407-3" @default.
• W4377164009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37211579" @default.
• W4377164009 hasPublicationYear "2023" @default.
• W4377164009 type Work @default.
• W4377164009 citedByCount "0" @default.
• W4377164009 crossrefType "journal-article" @default.
• W4377164009 hasAuthorship W4377164009A5002770606 @default.
• W4377164009 hasAuthorship W4377164009A5010003226 @default.
• W4377164009 hasAuthorship W4377164009A5032068938 @default.
• W4377164009 hasAuthorship W4377164009A5040004229 @default.
• W4377164009 hasAuthorship W4377164009A5081875581 @default.
• W4377164009 hasAuthorship W4377164009A5089705408 @default.
• W4377164009 hasAuthorship W4377164009A5091985933 @default.
• W4377164009 hasBestOaLocation W43771640091 @default.
• W4377164009 hasConcept C126322002 @default.
• W4377164009 hasConcept C134018914 @default.
• W4377164009 hasConcept C2777180221 @default.
• W4377164009 hasConcept C2777538456 @default.
• W4377164009 hasConcept C2779920387 @default.
• W4377164009 hasConcept C2780221984 @default.
• W4377164009 hasConcept C555293320 @default.
• W4377164009 hasConcept C71924100 @default.
• W4377164009 hasConceptScore W4377164009C126322002 @default.
• W4377164009 hasConceptScore W4377164009C134018914 @default.
• W4377164009 hasConceptScore W4377164009C2777180221 @default.
• W4377164009 hasConceptScore W4377164009C2777538456 @default.
• W4377164009 hasConceptScore W4377164009C2779920387 @default.
• W4377164009 hasConceptScore W4377164009C2780221984 @default.
• W4377164009 hasConceptScore W4377164009C555293320 @default.
• W4377164009 hasConceptScore W4377164009C71924100 @default.
• W4377164009 hasFunder F4320307781 @default.
• W4377164009 hasIssue "7" @default.
• W4377164009 hasLocation W43771640091 @default.
• W4377164009 hasLocation W43771640092 @default.
• W4377164009 hasLocation W43771640093 @default.
• W4377164009 hasOpenAccess W4377164009 @default.
• W4377164009 hasPrimaryLocation W43771640091 @default.
• W4377164009 hasRelatedWork W2010930004 @default.
• W4377164009 hasRelatedWork W2031287108 @default.
• W4377164009 hasRelatedWork W2128979963 @default.
• W4377164009 hasRelatedWork W2216053888 @default.
• W4377164009 hasRelatedWork W2270869067 @default.
• W4377164009 hasRelatedWork W2304371315 @default.
• W4377164009 hasRelatedWork W2375006128 @default.
• W4377164009 hasRelatedWork W2778104193 @default.
• W4377164009 hasRelatedWork W4211013991 @default.
• W4377164009 hasRelatedWork W4361279772 @default.
• W4377164009 hasVolume "14" @default.
• W4377164009 isParatext "false" @default.
• W4377164009 isRetracted "false" @default.
• W4377164009 workType "article" @default.